Cardium Therapeutics (CXM) Reports In-Line Q1 Loss of 2c/Share
Get Alerts CXM Hot Sheet
Price: $13.01 --0%
EPS Growth %: +33.3%
Financial Fact:
Research and development: 108.67K
Today's EPS Names:
SHIM, KOD, HEWA, More
EPS Growth %: +33.3%
Financial Fact:
Research and development: 108.67K
Today's EPS Names:
SHIM, KOD, HEWA, More
Join SI Premium – FREE
Cardium Therapeutics, Inc. (NYSE: CXM) reported Q1 EPS of ($0.02), versus ($0.02) reported last year.
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Recruit Holdings Co., Ltd (6098:JP) (RCRUY) PT Raised to JPY7,800 at Jefferies, 'emerged stronger since the last earnings season'
- Can-Fite BioPharma (CANF) Reports FY23 Results, Issues Clinical Update
- Truist Securities Starts Global Net Lease (GNL) at Hold, 'expect earnings growth will be muted'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!